Prologue Journal

Eli Lilly’s Mounjaro Approved for Weight Loss in the U.S.

• prologu5
• 11/08/202311/08/2023

Wall Street Journal

The drug, which will be sold as Zepbound as an anti-obesity treatment, had previously been cleared by the FDA for the treatment of Type 2 diabetes.

https://www.wsj.com/articles/eli-lillys-mounjaro-approved-for-weight-loss-in-the-u-s-d9589d84